Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarction

PharmacoEconomics

Volumn 20, Issue 3, 2002, Pages 195-201

  Darba J ^a   Izquierdo, I ^b   Pontes, C ^b   Navas, C ^b   Rovira, J ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Grupo Uriach   (Spain)

^c SOIKOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; SALICYLIC ACID DERIVATIVE; TRIFLUSAL;

ACUTE HEART INFARCTION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HEALTH ECONOMICS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

EID: 0036234718     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200220030-00005     Document Type: Article

References (28)

1. Mortalidad cardiovascular en España y sus comunidades autónomas (1975-1992)
2. Treatment for acute myocardial infarction: Overview of randomised clinical trials
3. Adjunctive drug therapy of acute myocardial infarction: Evidence from clinical trials
4. Routine medical management of acute myocardial infarction
5. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2
6. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various cathegories of patients
7. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite 2-hydroxy-4-trifluoro methylbenzoic acid
8. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients
9. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke
10. The European Stroke Prevention Study (ESPS): Principal end-points
11. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
12. Triflusal
13. Randomised comparative trial of triflusal an aspirin following acute myocardial infarction
14. Triflusal versus Aspirin in Secondary stroke prevention: Results of TACIP study
15. Protective effect of triflusal against acute myocardial infarction in patients with unstable angina: Results of a Spanish multicentre trial
16. Triflusal in the treatment of patients with chronic peripheral arteriopathy: Multicentre double-blind clinical study vs placebo
17. Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both asociated with dipyridamole: A randomized double-blind, placebo-controlled trial
18. Triflusal versus acetylsalicylic acid: A double-blind study for the prophylaxis of deep vein thrombosis after hip surgery
19. Platelet count, antiplatelet therapy and pulmonary embolism: A prospective study in patients with hip surgery
20. Diagnosis related group costs in a regulated environment: A note about their economic interpretation
21. Neurological patients' caring costs by diagnosis related group methodology
22. Production and costs analysis in an acute pathology patients hospital